Pseudomonas aeruginosa exploits lipid A and muropeptides modification as a strategy to lower innate immunity during cystic fibrosis lung infection C Cigana, L Curcurù, MR Leone, T Ieranò, NI Lorè, I Bianconi, A Silipo, ... PloS one 4 (12), e8439, 2009 | 186 | 2009 |
Cystic Fibrosis-Niche Adaptation of Pseudomonas aeruginosa Reduces Virulence in Multiple Infection Hosts NI Lorè, C Cigana, I De Fino, C Riva, M Juhas, S Schwager, L Eberl, ... PloS one 7 (4), e35648, 2012 | 141 | 2012 |
Modelling Co-Infection of the Cystic Fibrosis Lung by Pseudomonas aeruginosa and Burkholderia cenocepacia Reveals Influences on Biofilm Formation and Host … A Bragonzi, I Farulla, M Paroni, KB Twomey, L Pirone, NI Lorè, I Bianconi, ... PloS one 7 (12), e52330, 2012 | 137 | 2012 |
Inactivation of thyA in Staphylococcus aureus Attenuates Virulence and Has a Strong Impact on Metabolism and Virulence Gene Expression A Kriegeskorte, D Block, M Drescher, N Windmüller, A Mellmann, C Baum, ... MBio 5 (4), 10.1128/mbio. 01447-14, 2014 | 88* | 2014 |
Tracking the immunopathological response to Pseudomonas aeruginosa during respiratory infections C Cigana, NI Lorè, C Riva, I De Fino, L Spagnuolo, B Sipione, G Rossi, ... Scientific reports 6 (1), 21465, 2016 | 86 | 2016 |
Hepcidin levels predict Covid-19 severity and mortality in a cohort of hospitalized Italian patients A Nai, NI Lorè, A Pagani, R De Lorenzo, S Di Modica, F Saliu, DM Cirillo, ... American journal of hematology 96 (1), E32-E35, 2021 | 82 | 2021 |
Blood neurofilament light chain and total tau levels at admission predict death in COVID-19 patients R De Lorenzo, NI Loré, A Finardi, A Mandelli, DM Cirillo, C Tresoldi, ... Journal of neurology 268 (12), 4436-4442, 2021 | 77 | 2021 |
Thymidine-dependent Staphylococcus aureus small-colony variants are induced by trimethoprim-sulfamethoxazole (SXT) and have increased fitness during SXT challenge A Kriegeskorte, NI Lorè, A Bragonzi, C Riva, M Kelkenberg, K Becker, ... Antimicrobial agents and chemotherapy 59 (12), 7265-7272, 2015 | 71 | 2015 |
Activation of Human Toll-like receptor 4 (TLR4)· myeloid differentiation factor 2 (MD-2) by hypoacylated lipopolysaccharide from a clinical isolate of Burkholderia cenocepacia F Di Lorenzo, Ł Kubik, A Oblak, NI Lore, C Cigana, R Lanzetta, M Parrilli, ... Journal of Biological Chemistry 290 (35), 21305-21319, 2015 | 64 | 2015 |
CXCL10 levels at hospital admission predict COVID-19 outcome: hierarchical assessment of 53 putative inflammatory biomarkers in an observational study NI Lorè, R De Lorenzo, PMV Rancoita, F Cugnata, A Agresti, F Benedetti, ... Molecular medicine 27, 1-10, 2021 | 61 | 2021 |
Dampening Host Sensing and Avoiding Recognition in Pseudomonas aeruginosa Pneumonia C Cigana, NI Lore, ML Bernardini, A Bragonzi BioMed Research International 2011 (1), 852513, 2011 | 59 | 2011 |
Host genetic diversity influences the severity of Pseudomonas aeruginosa pneumonia in the Collaborative Cross mice NI Lorè, FA Iraqi, A Bragonzi BMC genetics 16, 1-6, 2015 | 56 | 2015 |
Adiponectin to leptin ratio reflects inflammatory burden and survival in COVID-19 L Di Filippo, R De Lorenzo, C Sciorati, A Capobianco, NI Lorè, A Giustina, ... Diabetes & Metabolism 47 (6), 101268, 2021 | 55 | 2021 |
IL-17A impairs host tolerance during airway chronic infection by Pseudomonas aeruginosa NI Lorè, C Cigana, C Riva, I De Fino, A Nonis, L Spagnuolo, B Sipione, ... Scientific reports 6 (1), 25937, 2016 | 53 | 2016 |
Factors contributing to epidemic MRSA clones replacement in a hospital setting R Baldan, F Testa, NI Lore, A Bragonzi, P Cichero, C Ossi, A Biancardi, ... Public Library of Science 7 (8), e43153, 2012 | 44 | 2012 |
The IL-17A/IL-17RA axis in pulmonary defence and immunopathology NI Lorè, A Bragonzi, C Cigana Cytokine & growth factor reviews 30, 19-27, 2016 | 41 | 2016 |
Persistent cystic fibrosis isolate Pseudomonas aeruginosa strain RP73 exhibits an under-acylated LPS structure responsible of its low inflammatory activity F Di Lorenzo, A Silipo, I Bianconi, NI Lore, A Scamporrino, L Sturiale, ... Molecular Immunology 63 (2), 166-175, 2015 | 41 | 2015 |
Host genetic background influences the response to the opportunistic Pseudomonas aeruginosa infection altering cell-mediated immunity and bacterial replication M De Simone, L Spagnuolo, NI Lorè, G Rossi, C Cigana, I De Fino, ... PloS one 9 (9), e106873, 2014 | 39 | 2014 |
Chronic infection by nontypeable Haemophilus influenzae fuels airway inflammation F Saliu, G Rizzo, A Bragonzi, L Cariani, DM Cirillo, C Colombo, V Daccò, ... ERJ open research 7 (1), 2021 | 30 | 2021 |
CFTR modulator therapies: potential impact on airway infections in cystic fibrosis F Saluzzo, L Riberi, B Messore, NI Loré, I Esposito, E Bignamini, ... Cells 11 (7), 1243, 2022 | 29 | 2022 |